Mantle Cell Lymphoma: Effectiveness of Maintenance Ibrutinib – Case Report

Krasowska Danuta, Szczepanek Aleksandra, Kozioł Magdalena, Szczepanek-Wąsik Ewa. Mantle Cell Lymphoma: Effectiveness of Maintenance Ibrutinib – Case Report. Journal of Education, Health and Sport. 2020;10(9):299307. eISSN 2391-8306. DOI http://dx.doi.org/10.12775/JEHS.2020.10.09.034 https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/JEHS.2020.10.09.034 https://zenodo.org/record/4026817 The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019. © The Authors 2020; This article is published with open access at Licensee Open Journal Systems of Nicolaus Copernicus University in Torun, Poland Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike. (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. The authors declare that there is no conflict of interests regarding the publication of this paper. Received: 20.08.2020. Revised: 25.08.2020. Accepted: 13.09.2020. Mantle Cell Lymphoma: Effectiveness of Maintenance Ibrutinib – Case Report Danuta Krasowska1, Aleksandra Szczepanek2, Magdalena Kozioł3 , Ewa Szczepanek-Wąsik2 1 Students’ Scientific Association at the Department of Dermatology, Venerology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 11, Lublin 20-081, Poland. 2 Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, ul. Staszica 11, 20-080 Lublin, Poland 3 Student Scientific Association at Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, ul. Radziwiłłowska 11, Lublin 20-080, Poland; Corresponding author: Danuta Krasowska, dana.krasowska@gmail.com Danuta Krasowska https://orcid.org/0000-0002-3015-1120, dana.krasowska@gmail.com Aleksandra Szczepanek https://orcid.org/0000-0003-3953-1784, szczepanekal@gmail.com Magdalena Kozioł https://orcid.org/0000-0002-8671-5968, magdalena.koziol@icloud.com Ewa Szczepanek–Wąsik https://orcid.org/0000-0002-9715-3745, ewawsz@poczta.onet.pl Key words: mantle cell lymphoma, ibrutinib, maintenance therapy Abstract Mantle cell lymphoma is a rare subtype of non- Hodgkin lymphoma with life-threatening course of disease. It mostly affects older adults in their sixth or seventh decade of life with male to female predominance of 3 to 1. It prognosis is very poor and the treatment is demanding. The golden standard therapy for younger, fit patients